Welcome to the Hope Bio Blog

By Jan Shultis During the last few weeks of 2025, Houston-area clinical research organization Hope Biosciences Research Foundation (HBRF) received Food and Drug Administration (FDA) authorization to administer Hope Biosciences’ allogeneic (donor) adipose-derived mesenchymal (adult) stem cells (HB-adMSCs) to seven men and women living with Multiple System Atrophy (MSA). As HBRF shared in their announcement , the occasion is noteworthy both for authorization of research in a r

A Mid-year Introduction to Hope Bio's Community | Written by Jan Shultis About six months ago, did you resolve that this would be a new year, and a new "you"? As summer proceeds and coaches in seemingly every field start to ask how we're doing with those resolutions set back in January, maybe it's time for a pivot - what about “new year, same you,” but “now healthier and optimally protected against threats like degenerative disease or catastrophic illness?” If that resonates,

Hope Biosciences welcomes the workforce of the future